Bivariate sequential designs for phase II trials

Biometrics

Volumn 51, Issue 2, 1995, Pages 656-664

  Conaway, M R ^a   Petroni, G R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical trial; Dependent binary; Group sequential

Indexed keywords

ANTITUMOUR ACTIVITY; BIVARIATE; CLINICAL TRIAL; DEPENDENT BINARY; EXACT DISTRIBUTION; GROUP SEQUENTIAL; PHASE II; SEQUENTIAL DESIGN; STOPPING RULE;

DESIGN;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DRUG CYTOTOXICITY; DRUG RESEARCH; HUMAN; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; SAMPLING; STATISTICAL ANALYSIS;

EID: 0029117666     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2532952     Document Type: Article

References (0)